Condition
Apoplexy; Brain
Total Trials
3
Recruiting
0
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Active Not Recruiting1
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04648449Active Not Recruiting
Artificial Intelligence (AI) Support in Medical Emergency Calls
NCT03094715Not ApplicableTerminated
Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window
NCT04688489Not ApplicableCompletedPrimary
Effect of Carbloading and Maltodextrin on the Level of Function in Patients With Apoplexia
Showing all 3 trials